| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue | 2,955 | 2,927 | 9,717 | | | Gross Profit | (2,955) | (2,927) | (9,717) | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,809 | 2,162 | 2,915 | | Non Recurring |
-
|
-
| 3,244 | | Others | 190 | 128 | 92 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,954) | (5,217) | (15,968) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 63 | 40 | 45 | | Earnings Before Interest And Taxes | (5,891) | (5,177) | (11,836) | | Interest Expense | 15 | 15 | 152 | | Income Before Tax | (5,906) | (5,192) | (11,988) | | Income Tax Expense | (73) |
-
| (436) | | Minority Interest |
-
|
-
| 4,087 | | | | Net Income From Continuing Ops | (5,833) | (5,192) | (11,552) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,833) | (5,192) | (11,552) | | Preferred Stock And Other Adjustments | 1,292 | 1,215 |
-
| | | Net Income Applicable To Common Shares | ($4,541) | ($3,977) | ($11,552) |
|
0.13% Nasdaq 
Income Statement
